Dr. Cohen will focus on the essential role of clinical drug trials in developing new treatments for Alzheimer's disease. The different stages of testing will be outlined as well as the impact of trials on participants.
When: Wednesday September 5, 2012 5:30pm-7:30pm
Where: Alzheimer Society of Toronto, 20 Eglinton Ave W, 16th Floor, Toronto
Registration is FREE.
Contact Indra Moffett to register 416-640-6307 imoffett@alzheimertoronto.org